Immunogenicity of Third Dose COVID-19 Vaccine Strategies in Patients Who Are Immunocompromised with Suboptimal Immunity Following Two Doses (OCTAVE-DUO): an Open-Label, Multicentre, Randomised, Controlled, Phase 3 Trial Carl S. Goodyear , Amit Patel , Eleanor Barnes , Michelle Willicombe , Stefan Siebert , Thushan I. de Silva , John A. Snowden , Sean H. Lim , Sarah J. Bowden , Lucinda Billingham , Alex Richter , Miles Carroll , Edward J. Carr , Rupert Beale , Daniel Rea , Helen Parry , Sarah Pirrie , Zixiang Lim , Jack Satsangi , Susanna J. Dunachie , Gordon Cook , Paul Miller , Neil Basu , Ashley Gilmour , Anne-Marie Hodgkins , Lili Evans , Ana Hughes , Stephanie Longet , Georgina Meacham , Kwee L. Yong , Matthew J. A'Hearne , Mickey B. C. Koh , Siobhan O. Burns , Kim Orchard , Caron Paterson , Graham McIlroy , Sam M. Murray , Tina Thomson , Stavros Dimitriadis , Lyndsey Goulston , Samantha Miller , Victoria Keillor , Maria Prendecki , David Thomas , Amanda Kirkham , Iain B. McInnes , Pamela Kearns LANCET RHEUMATOLOGY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
